Aug 2026· Molecular Psychiatry· 0 citations· 25 references
Medicine
TL;DR
It is indicated that the causal effect of BMI on depression detected in typical non-clustered Mendelian randomization is driven to an extent by appetite, with no or inconsistent evidence for effects on core psychological symptoms such as anhedonia and depressed mood.
Abstract
While BMI is phenotypically and genetically associated with depression, the extent to which BMI causes depression and the mechanisms underlying this effect remain unclear. We estimated the causal effect of BMI on depression symptoms, accounting for complexity in both the exposure and the outcome. We applied PheWAS-based Clustering of Mendelian Randomization instruments (PWC-MR) to partition 324 BMI-associated SNPs into six genetic clusters and estimated the effect of each cluster on nine depression symptoms from the largest available genome-wide meta-analysis of PHQ-9 depression symptoms (N = 224,535-308,421). Across all six clusters, BMI had the largest effect on appetite changes (β ranges from 0.19 to 0.34), which was robust across estimators, homogeneous across clusters, and survived correction for multiple testing. Smaller effects were observed for several other symptoms, including concentration changes, fatigue, anhedonia, and sleep problems, but these were heterogeneous across clusters and often attenuated under pleiotropy-robust estimators, indicating likely bias from horizontal pleiotropy. Little evidence of an effect was detected for depressed mood and suicidal ideation. Cluster-level heterogeneity was observed for the majority of symptoms, demonstrating that the causal effect of BMI varies by instrument group and indicating likely violation of the exclusion restriction assumption. These findings indicate that the causal effect of BMI on depression detected in typical non-clustered Mendelian randomization is driven to an extent by appetite, with no or inconsistent evidence for effects on core psychological symptoms such as anhedonia and depressed mood.
To investigate the causal relevance of melatonin metabolism, which provides the biological basis for circulating melatonin levels, to specific depression symptom subtypes, we performed a targeted systematic review of melatonin metabolism pathways in the human brain and liver. Using two-sample Mendelian randomization (MR), we assessed the causal effects of metabolism pathways and/or individual genes on major depressive disorder (MDD) and nine symptom subtypes derived from Patient Health Questionnaire-9 (PHQ-9). Instrumental variables (IVs) were expression quantitative trait loci (eQTL) for eight individual genes, one synthesis route, and three degradation routes. Results were assessed using Bayesian colocalization and phenome-wide association analyses. At the pathway-level, the genetically proxied synthesis-route signal was associated with PHQ-9 Assessment 5 (PHQ9A5, OR: 0.89, 95% CI: 0.85-0.93), but sensitivity analyses suggested this association was primarily driven by TPH1 and may reflect serotonin-related biology. In contrast, higher brain melatonin degradation raised the risk of both PHQ9A1 (OR: 1.03, 95% CI: 1.02-1.04) and PHQ9A7 (OR: 1.03, 95% CI: 1.02-1.03). Within degradation, up-regulation of the kynurenine sub-pathway increased the odds of PHQ9A3 (OR: 1.05, 95% CI: 1.02-1.07), PHQ9A4 (OR = 1.04, 95% CI: 1.02-1.06) and PHQ9A7 (OR: 1.05, 95% CI: 1.02-1.07). Gene-level analyses were largely concordant, except for SULT1A1, whose higher expression was genetically protective for PHQ9A3 but risk-increased for PHQ9A1 and PHQ9A4. Overall, these results demonstrate that melatonin metabolism exerts symptom-specific and pathway-specific causal effects on depression. A stratified view of melatonin's role may help optimize the application of exogenous melatonin supplementation.
Yuanbi Wang, Wen Wen, Hansheng Chen et al.· Journal of Affective Disorde...· 0 citations
These findings provide a hypothesis-generating reframing of the traditional comorbidity model, suggesting that divergent molecular programs may converge on shared pathways and offer a preliminary foundation for exploring therapeutic strategies at the mood–metabolism interface.
Xingpei Li, Chunling Chen, Huibin Li et al.· Frontiers in Genetics· 0 citations
Findings support an immunometabolic interpretation in which EBV-related immune responses and plasma metabolite remodeling may be relevant to depression vulnerability, and they prioritize candidate metabolites and pathways for future mechanistic and clinical investigation.
Yuan Zhang, Feipeng Chen, Guoying Song et al.· Translational Psychiatry· 0 citations
It is found that schizophrenia and ADHD show distinct genetic patterns: schizophrenia shares more genetic factors with brain structure and diabetes, while ADHD is more strongly linked to metabolic pathways.
J. Kopal, A. Shadrin, Dennis van der Meer et al.· Communications Medicine· 0 citations
Both ACEs and genetic burden of depression are associated with an increased risk of depressive symptoms, and their joint effects significantly increase the risk of all types of depressive symptoms.
Feng Chen, Yue Zhu, Jiajun Li et al.· Stress and Health· 0 citations